|
|
Table 2.
MRI measurements at baseline and after 12 mo of cross-sex hormone
administration in M-F and F-M transsexuals
|
|
|
M-F Transsexuals
|
F-M Transsexuals
|
| Baseline |
After 12 mo
|
95% CI of difference |
P value |
Baseline
|
After 12 mo |
95% CI of difference |
P value
|
|
| Subcutaneous fat, cm2 |
| Abdomen |
87 ± 43 |
137 ± 52 |
(39; 61) |
<0.001 |
164 ± 90 |
136 ± 71 |
( 45; 10) |
<0.01 |
| Hip
|
91 ± 48 |
151 ± 49 |
(48; 73) |
<0.001
|
175 ± 70 |
129 ± 54 |
( 57; 35)
|
<0.001 |
| Thigh |
123 ± 58 |
204 ± 57 |
(64; 96) |
<0.001 |
244 ± 78 |
188 ± 61 |
( 69; 42) |
<0.001 |
| Visceral fat, cm2
|
40 ± 19 |
47 ± 18 |
(2; 12) |
0.01
|
39 ± 16 |
44 ± 19 |
(2; 9) |
<0.01 |
| V/S
|
0.50 ± 0.18 |
0.37 ± 0.14 |
( 0.18; 0.07)
|
<0.001 |
0.27 ± 0.08 |
0.35 ± 0.10 |
(0.06; 0.11) |
<0.001 |
| Muscle area, cm2
|
307 ± 47 |
278 ± 37 |
( 38; 20)
|
<0.001 |
239 ± 33 |
285 ± 36 |
(39; 54)
|
<0.001 |
| Total area, cm2 |
| Abdomen
|
374 ± 74 |
416 ± 87 |
(24; 60) |
<0.001
|
406 ± 110 |
413 ± 92 |
( 9; 23)
|
NS |
| Hip |
538 ± 88 |
594 ± 95 |
(42; 69) |
<0.001 |
576 ± 110 |
564 ± 97 |
( 26; 2) |
0.09 |
| Thigh |
441 ± 92 |
497 ± 93 |
(36; 76) |
<0.001 |
494 ± 102 |
484 ± 82 |
( 28; 8) |
NS |
| WHR area,
cm2/cm2 |
0.69 ± 0.07 |
0.70 ± 0.08 |
( 0.02; 0.03) |
NS
|
0.70 ± 0.10 |
0.73 ± 0.08 |
(0.00; 0.06)
|
<0.05 |
|
|
Values are means ± SD. CI, confidence interval; V/S, ratio of
visceral to subcutaneous abdominal fat area; WHR, waist-to-hip ratio;
NS, not significant.
|
|